Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Low Blood Sugar Articles

Lilly Launches Glucagon Mobile App
Reminding Myself That My Life Is More Than Diabetes
Standing Together
Making a Healthy Choice for Breakfast
Vitamin Deficiencies in People With Diabetes: the Supplements You Need
Driving Safely With Type 1 Diabetes
Hypoglycemia Affects Productivity at Work
Standing Up For Sugar, the Hypoglycemia Alert Dog  
Dog Sense
Helping African Americans F.A.C.E. Their Risk for Diabetes
Diabetes Health Reference Charts
Mail Order Reference Guide (PDF)
Fast Acting Glucose Reference Guide (PDF)
Blood Glucose Meters Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Continuous Glucose Monitors Reference Guide (PDF)
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
See All Charts…
Low Blood Sugar Archives
Browse the Low Blood Sugar Archives
Subscribe to the Complications & Care RSS Feed
Print | Email | Share | Comments (0)

On the Horizon

Jan 1, 2005

A New Therapy for Type 2s

Exenatide (synthetic exendin-4) significantly reduced A1C in patients with type 2 diabetes who were failing maximum doses of a sulfonylurea, according to researchers at the University of North Carolina School of Medicine in Chapel Hill, North Carolina, and the Veterans Medical Center at the University of California San Diego. Exenatide was well tolerated and associated with weight loss.

In a 30-week study conducted at 101 sites in the United States, 377 subjects were randomized to receive exenatide injected subcutaneously twice daily (before breakfast and dinner) or placebo.

The most common adverse events were generally mild or moderate and gastrointestinal in nature. No severe hypoglycemia was observed.

Categories: A1c Test, Diabetes, Diabetes, Low Blood Sugar, Medications, Type 2 Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Jan 1, 2005

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.